{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:03:11Z","timestamp":1792854191338,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.spen.2020.100835","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T21:07:22Z","timestamp":1593032842000},"page":"100835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder"],"prefix":"10.1016","volume":"35","author":[{"given":"Richard E.","family":"Frye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Scahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harris","family":"Huberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2020.100835_bib0001","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.spen.2020.100835_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6904a1","article-title":"Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016","volume":"69","author":"Maenner","year":"2020","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.spen.2020.100835_bib0003","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jcpp.12037","article-title":"Optimal outcome in individuals with a history of autism","volume":"54","author":"Fein","year":"2013","journal-title":"J Child Psychol Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0004","doi-asserted-by":"crossref","first-page":"e1112","DOI":"10.1542\/peds.2011-1601","article-title":"Six developmental trajectories characterize children with autism","volume":"129","author":"Fountain","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2020.100835_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cpr.2013.11.002","article-title":"Cognitive, language, social and behavioural outcomes in adults with autism spectrum disorders: a systematic review of longitudinal follow-up studies in adulthood","volume":"34","author":"Magiati","year":"2014","journal-title":"Clin Psychol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.spen.2020.100835_bib0006","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1542\/peds.2012-0900J","article-title":"Clinical practice pathways for evaluation and medication choice for attention-deficit\/hyperactivity disorder symptoms in autism spectrum disorders","volume":"130","author":"Mahajan","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2020.100835_bib0007","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","article-title":"Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity","volume":"62","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2020.100835_bib0008","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","article-title":"Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder","volume":"172","author":"Scahill","year":"2015","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004677.pub3","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","author":"Williams","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.spen.2020.100835_bib0010","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nbt0810-772","article-title":"Drugmakers dance with autism","volume":"28","author":"Webb","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.spen.2020.100835_bib0011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/DHPS.S39595","article-title":"Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder","volume":"6","author":"Frye","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.spen.2020.100835_bib0012","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40263-018-0556-y","article-title":"Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents","volume":"32","author":"Frye","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.spen.2020.100835_bib0013","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrd4102","article-title":"Drug discovery for autism spectrum disorder: challenges and opportunities","volume":"12","author":"Ghosh","year":"2013","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.spen.2020.100835_bib0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/CMPed.S38337","article-title":"Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes","volume":"10","author":"Frye","year":"2016","journal-title":"Clin Med Insights Pediatr"},{"key":"10.1016\/j.spen.2020.100835_bib0015","doi-asserted-by":"crossref","first-page":"PI15","DOI":"10.12659\/MSM.881792","article-title":"A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders","volume":"17","author":"Geier","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.spen.2020.100835_bib0016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rasd.2012.07.006","article-title":"l-Carnitine supplementation improves the behavioral symptoms in autistic children","volume":"7","author":"Fahmy","year":"2013","journal-title":"Research in Autism Spectrum Disorders."},{"key":"10.1016\/j.spen.2020.100835_bib0017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nurt.2010.05.004","article-title":"Tetrahydrobiopterin as a novel therapeutic intervention for autism","volume":"7","author":"Frye","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.spen.2020.100835_bib0018","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/cap.2012.0127","article-title":"Tetrahydrobiopterin as a treatment for autism spectrum disorders: a double-blind, placebo-controlled trial","volume":"23","author":"Klaiman","year":"2013","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"10.1016\/j.spen.2020.100835_bib0019","doi-asserted-by":"crossref","first-page":"15550","DOI":"10.1073\/pnas.1416940111","article-title":"Sulforaphane treatment of autism spectrum disorder (ASD)","volume":"111","author":"Singh","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.spen.2020.100835_bib0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0278-5846(94)90074-4","article-title":"Folic acid in neurodevelopment and child psychiatry","volume":"18","author":"Greenblatt","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.spen.2020.100835_bib0021","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1177\/15648265080292S117","article-title":"Effects of vitamin B12 and folate deficiency on brain development in children","volume":"29","author":"Black","year":"2008","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.spen.2020.100835_bib0022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/bmm-2017-0109","article-title":"Folate metabolism abnormalities in autism: potential biomarkers","volume":"11","author":"Frye","year":"2017","journal-title":"Biomark Med"},{"key":"10.1016\/j.spen.2020.100835_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gde.2012.03.002","article-title":"Genetic architecture in autism spectrum disorder","volume":"22","author":"Devlin","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.spen.2020.100835_bib0024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11011","article-title":"Patterns and rates of exonic de novo mutations in autism spectrum disorders","volume":"485","author":"Neale","year":"2012","journal-title":"Nature."},{"key":"10.1016\/j.spen.2020.100835_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature10945","article-title":"De novo mutations revealed by whole-exome sequencing are strongly associated with autism","volume":"485","author":"Sanders","year":"2012","journal-title":"Nature."},{"key":"10.1016\/j.spen.2020.100835_bib0026","first-page":"52","article-title":"Central tetrahydrobiopterin concentration in neurodevelopmental disorders","volume":"4","author":"Frye","year":"2010","journal-title":"Front Neurosci"},{"key":"10.1016\/j.spen.2020.100835_bib0027","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1038\/tp.2013.14","article-title":"Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study","volume":"3","author":"Frye","year":"2013","journal-title":"Transl Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2007.05.025","article-title":"Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism","volume":"422","author":"Adams","year":"2007","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.spen.2020.100835_bib0029","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141B","author":"James","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"10.1016\/j.spen.2020.100835_bib0030","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: systematic review and meta-analyses","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic Biol Med."},{"key":"10.1016\/j.spen.2020.100835_bib0031","first-page":"106","article-title":"Association of MTHFR gene variants with autism","volume":"9","author":"Boris","year":"2004","journal-title":"Journal of American Physicians and Surgeons."},{"key":"10.1016\/j.spen.2020.100835_bib0032","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YPG.0b013e32832cebd2","article-title":"Aberrations in folate metabolic pathway and altered susceptibility to autism","volume":"19","author":"Mohammad","year":"2009","journal-title":"Psychiatr Genet."},{"key":"10.1016\/j.spen.2020.100835_bib0033","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/gtmb.2012.0091","article-title":"Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population","volume":"16","author":"Guo","year":"2012","journal-title":"Genet Test Mol Biomarkers."},{"key":"10.1016\/j.spen.2020.100835_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3945\/ajcn.110.004416","article-title":"Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study","volume":"96","author":"Schmidt","year":"2012","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.spen.2020.100835_bib0035","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10803-010-1120-x","article-title":"Population- and family-based studies associate the MTHFR gene with idiopathic autism in simplex families","volume":"41","author":"Liu","year":"2011","journal-title":"J Autism Dev Disord."},{"key":"10.1016\/j.spen.2020.100835_bib0036","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/aur.70","article-title":"The MTHFR 677C\u2013>T polymorphism and behaviors in children with autism: exploratory genotype-phenotype correlations","volume":"2","author":"Goin-Kochel","year":"2009","journal-title":"Autism Res."},{"key":"10.1016\/j.spen.2020.100835_bib0037","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1111\/j.1582-4934.2008.00463.x","article-title":"One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders","volume":"13","author":"Pasca","year":"2009","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.spen.2020.100835_bib0038","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/aur.1300","article-title":"Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis","volume":"6","author":"Pu","year":"2013","journal-title":"Autism Res"},{"key":"10.1016\/j.spen.2020.100835_bib0039","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4161\/epi.1.4.3514","article-title":"Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation","volume":"1","author":"Nagarajan","year":"2006","journal-title":"Epigenetics."},{"key":"10.1016\/j.spen.2020.100835_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-016-9151-z","article-title":"Differential methylation at the RELN gene promoter in temporal cortex from autistic and typically developing post-puberal subjects","volume":"8","author":"Lintas","year":"2016","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.spen.2020.100835_bib0041","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1093\/cercor\/bhx250","article-title":"Dysregulation of Cortical Neuron DNA Methylation Profile in Autism Spectrum Disorder","volume":"27","author":"Nardone","year":"2017","journal-title":"Cereb Cortex."},{"key":"10.1016\/j.spen.2020.100835_bib0042","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1038\/tp.2012.61","article-title":"Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0043","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12311-010-0223-4","article-title":"Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD)","volume":"10","author":"Sajdel-Sulkowska","year":"2011","journal-title":"Cerebellum."},{"key":"10.1016\/j.spen.2020.100835_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005385","article-title":"Classification and adaptive behavior prediction of children with autism spectrum disorder based upon multivariate data analysis of markers of oxidative stress and DNA methylation","volume":"13","author":"Howsmon","year":"2017","journal-title":"PLoS Comput Biol."},{"key":"10.1016\/j.spen.2020.100835_bib0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/btm2.10095","article-title":"Multivariate techniques enable a biochemical classification of children with autism spectrum disorder versus typically-developing peers: A comparison and validation study","volume":"3","author":"Howsmon","year":"2018","journal-title":"Bioeng Transl Med."},{"key":"10.1016\/j.spen.2020.100835_bib0046","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2002-37082","article-title":"Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution","volume":"33","author":"Ramaekers","year":"2002","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.spen.2020.100835_bib0047","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa043160","article-title":"Autoantibodies to folate receptors in the cerebral folate deficiency syndrome","volume":"352","author":"Ramaekers","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.spen.2020.100835_bib0048","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mp.2011.175","article-title":"Cerebral folate receptor autoantibodies in autism spectrum disorder","volume":"18","author":"Frye","year":"2013","journal-title":"Mol Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0049","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10545-018-0224-x","article-title":"Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience","volume":"41","author":"Batllori","year":"2018","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.spen.2020.100835_bib0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneurol.2011.80","article-title":"Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects","volume":"68","author":"Perez-Duenas","year":"2011","journal-title":"Arch Neurol."},{"key":"10.1016\/j.spen.2020.100835_bib0051","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2009.08.005","article-title":"Cerebral folate deficiency and CNS inflammatory markers in Alpers disease","volume":"99","author":"Hasselmann","year":"2010","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.spen.2020.100835_bib0052","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0028-3886.253623","article-title":"Complex heterozygous polymerase gamma mutation and cerebral folate deficiency in a child with refractory partial status","volume":"67","author":"Samanta","year":"2019","journal-title":"Neurol India"},{"key":"10.1016\/j.spen.2020.100835_bib0053","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-8749.2004.tb00451.x","article-title":"Cerebral folate deficiency","volume":"46","author":"Ramaekers","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2020.100835_bib0054","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa0803783","article-title":"Lack of association between folate-receptor autoantibodies and neural-tube defects","volume":"361","author":"Molloy","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.spen.2020.100835_bib0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mp.2012.22","article-title":"Role of folate receptor autoantibodies in infantile autism","volume":"18","author":"Ramaekers","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2020.100835_bib0056","article-title":"Improving Outcome in Infantile Autism with Folate Receptor Autoimmunity and Nutritional Derangements: A Self-Controlled Trial","volume":"2019","author":"Ramaekers","year":"2019","journal-title":"Autism Res Treat."},{"key":"10.1016\/j.spen.2020.100835_bib0057","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2020.04.019","article-title":"Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial","volume":"173","author":"Renard","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.spen.2020.100835_bib0058","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/aur.1934","article-title":"Folate receptor autoantibodies are prevalent in children diagnosed with autism spectrum disorder, their normal siblings and parents","volume":"11","author":"Quadros","year":"2018","journal-title":"Autism Res."},{"key":"10.1016\/j.spen.2020.100835_bib0059","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/YPG.0b013e32833a2220","article-title":"MTHFR C677T is not a risk factor for autism spectrum disorders in South Brazil","volume":"20","author":"dos Santos","year":"2010","journal-title":"Psychiatr Genet."},{"key":"10.1016\/j.spen.2020.100835_bib0060","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/01.WNL.0000154641.08211.B7","article-title":"Cerebral folate deficiency with developmental delay, autism, and response to folinic acid","volume":"64","author":"Moretti","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.spen.2020.100835_bib0061","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-2008-1065354","article-title":"Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.spen.2020.100835_bib0062","article-title":"Characteristics of children who lost the diagnosis of autism: a sample from istanbul, Turkey","volume":"2014","author":"Mukaddes","year":"2014","journal-title":"Autism Res Treat"},{"key":"10.1016\/j.spen.2020.100835_bib0063","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1044\/1092-4388(2009\/08-0136)","article-title":"Defining spoken language benchmarks and selecting measures of expressive language development for young children with autism spectrum disorders","volume":"52","author":"Tager-Flusberg","year":"2009","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.spen.2020.100835_bib0064","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1044\/1092-4388(2007\/047)","article-title":"Predicting outcomes of children referred for autism using the MacArthur-Bates Communicative Development Inventory","volume":"50","author":"Luyster","year":"2007","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.spen.2020.100835_bib0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/1469-7610.00141","article-title":"Predictors of outcome among high functioning children with autism and Asperger syndrome","volume":"44","author":"Szatmari","year":"2003","journal-title":"J Child Psychol Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0066","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1037\/0022-006X.75.4.594","article-title":"Patterns of growth in verbal abilities among children with autism spectrum disorder","volume":"75","author":"Anderson","year":"2007","journal-title":"J Consult Clin Psychol."},{"key":"10.1016\/j.spen.2020.100835_bib0067","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11597200-000000000-00000","article-title":"Preference-based health-related quality-of-life outcomes in children with autism spectrum disorders: a comparison of generic instruments","volume":"30","author":"Tilford","year":"2012","journal-title":"Pharmacoeconomics."},{"key":"10.1016\/j.spen.2020.100835_bib0068","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1093\/cercor\/bhu211","article-title":"Neuroanatomy of Individual Differences in Language in Adult Males with Autism","volume":"25","author":"Lai","year":"2015","journal-title":"Cereb Cortex."},{"key":"10.1016\/j.spen.2020.100835_bib0069","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mp.2016.168","article-title":"Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial","volume":"23","author":"Frye","year":"2018","journal-title":"Mol Psychiatry."},{"key":"10.1016\/j.spen.2020.100835_bib0070","doi-asserted-by":"crossref","first-page":"41R","DOI":"10.1203\/PDR.0b013e318212f16b","article-title":"Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders","volume":"69","author":"Frye","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.spen.2020.100835_bib0071","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40291-018-0352-x","article-title":"Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder","volume":"22","author":"Rose","year":"2018","journal-title":"Mol Diagn Ther."},{"key":"10.1016\/j.spen.2020.100835_bib0072","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2020.100835_bib0073","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51034","article-title":"Developmental regression and mitochondrial function in children with autism","author":"Singh","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1016\/j.spen.2020.100835_bib0074","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.drudis.2015.07.002","article-title":"Can folic acid have a role in mitochondrial disorders?","volume":"20","author":"Ormazabal","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.spen.2020.100835_bib0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature25460","article-title":"Mitochondrial translation requires folate-dependent tRNA methylation","volume":"554","author":"Morscher","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.spen.2020.100835_bib0076","unstructured":"Delhey, L.M., Nur Kilinc, E., Yin, L., et al. The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder. J Clin Med. 62017."},{"key":"10.1016\/j.spen.2020.100835_bib0077","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2012.155925","article-title":"Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children","volume":"309","author":"Suren","year":"2013","journal-title":"Jama."},{"key":"10.1016\/j.spen.2020.100835_bib0078","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s10803-008-0591-5","article-title":"Abnormal transmethylation\/transsulfuration metabolism and DNA hypomethylation among parents of children with autism","volume":"38","author":"James","year":"2008","journal-title":"J Autism Dev Disord."},{"key":"10.1016\/j.spen.2020.100835_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152249","article-title":"Exposure to Folate Receptor Alpha Antibodies during Gestation and Weaning Leads to Severe Behavioral Deficits in Rats: A Pilot Study","volume":"11","author":"Sequeira","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.spen.2020.100835_bib0080","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/mp.2016.153","article-title":"Prevention of behavioral deficits in rats exposed to folate receptor antibodies: implication in autism","volume":"22","author":"Desai","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2020.100835_bib0081","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s10803-016-2782-9","article-title":"Measuring Changes in Social Communication Behaviors: Preliminary Development of the Brief Observation of Social Communication Change (BOSCC)","volume":"46","author":"Grzadzinski","year":"2016","journal-title":"J Autism Dev Disord."},{"key":"10.1016\/j.spen.2020.100835_bib0082","doi-asserted-by":"crossref","first-page":"792","DOI":"10.21037\/atm.2019.11.53","article-title":"Emerging biomarkers in autism spectrum disorder: a systematic review","volume":"7","author":"Frye","year":"2019","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.spen.2020.100835_bib0083","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/0006-2952(90)90583-7","article-title":"Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells","volume":"40","author":"Boarman","year":"1990","journal-title":"Biochem Pharmacol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909120300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909120300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:36:37Z","timestamp":1761028597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909120300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":83,"alternative-id":["S1071909120300462"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2020.100835","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2020.100835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100835"}}